vorasidenib
servier
['indigo', 'vorasidenib']
a breakthrough in #neurooncology at #asco23! with the idh inhibitor vorasidenib significantly improving progression-free survival in low-grade glioma patients, the future looks brighter. excited for what's next in our fight against brain cancer. #indigotrial #cancerinnovation 
MD Candidate @HarvardMed, @riceuniversity alum. Passionate about neurosurgery, cancer immunology, journalism, bioethics &  med humanities. Outdoor enthusiast